Kneteman, Norman M <br/><br/>
HCV796: A selective nonstructural protein 5B polymerase inhibitor with potent anti-hepatitis C virus activity in vitro, in mice with chimeric human livers, and in humans infected with hepatitis C virus.  [electronic resource] 

 -  Hepatology (Baltimore, Md.)  Mar 2009 
 - 745-52 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase I; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1527-3350 
<br/><br/><label>Standard No.: </label>10.1002/hep.22717  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antiviral Agents--pharmacology<br/>Benzofurans--pharmacology<br/>Disease Models, Animal<br/>Dose-Response Relationship, Drug<br/>Double-Blind Method<br/>Drug Therapy, Combination<br/>Enzyme Inhibitors--pharmacology<br/>Hepacivirus--drug effects<br/>Hepatitis C--drug therapy<br/>Hepatocytes--transplantation<br/>Humans<br/>Interferon alpha-2<br/>Interferon-alpha--therapeutic use<br/>Liver--drug effects<br/>Mice<br/>Mice, SCID<br/>Polyethylene Glycols<br/>Recombinant Proteins<br/>Replicon--drug effects<br/>Ribavirin--therapeutic use<br/>Sulfonamides--pharmacology<br/>Viral Nonstructural Proteins--antagonists & inhibitors